These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35660786)

  • 1. Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis.
    Rees NP; Shaheen W; Quince C; Tselepis C; Horniblow RD; Sharma N; Beggs AD; Iqbal TH; Quraishi MN
    EBioMedicine; 2022 Jul; 81():104088. PubMed ID: 35660786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.
    Zhang B; Yang L; Ning H; Cao M; Chen Z; Chen Q; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Xuan J; Li X; Lin A; He J; Zhang L; Hou X; Zeng Q; Xiao C
    Microbiol Spectr; 2023 Feb; 11(1):e0215921. PubMed ID: 36472435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.
    Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R
    Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
    Ishikawa D; Sasaki T; Takahashi M; Kuwahara-Arai K; Haga K; Ito S; Okahara K; Nakajima A; Shibuya T; Osada T; Hiramatsu K; Watanabe S; Nagahara A
    Inflamm Bowel Dis; 2018 Nov; 24(12):2590-2598. PubMed ID: 30124831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
    Kump P; Wurm P; Gröchenig HP; Wenzl H; Petritsch W; Halwachs B; Wagner M; Stadlbauer V; Eherer A; Hoffmann KM; Deutschmann A; Reicht G; Reiter L; Slawitsch P; Gorkiewicz G; Högenauer C
    Aliment Pharmacol Ther; 2018 Jan; 47(1):67-77. PubMed ID: 29052237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
    Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation for ulcerative colitis.
    Matsuoka K
    Immunol Med; 2021 Mar; 44(1):30-34. PubMed ID: 32663072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
    Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
    BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Lima SF; Gogokhia L; Viladomiu M; Chou L; Putzel G; Jin WB; Pires S; Guo CJ; Gerardin Y; Crawford CV; Jacob V; Scherl E; Brown SE; Hambor J; Longman RS
    Gastroenterology; 2022 Jan; 162(1):166-178. PubMed ID: 34606847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Shi Y; Dong Y; Huang W; Zhu D; Mao H; Su P
    PLoS One; 2016; 11(6):e0157259. PubMed ID: 27295210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation.
    Chen Q; Fan Y; Zhang B; Yan C; Zhang Q; Ke Y; Chen Z; Wang L; Shi H; Hu Y; Huang Q; Su J; Xie C; Zhang X; Zhou L; Ren J; Xu H
    Microbiol Spectr; 2023 Jun; 11(3):e0415222. PubMed ID: 37093057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients.
    Nusbaum DJ; Sun F; Ren J; Zhu Z; Ramsy N; Pervolarakis N; Kunde S; England W; Gao B; Fiehn O; Michail S; Whiteson K
    FEMS Microbiol Ecol; 2018 Sep; 94(9):. PubMed ID: 30010747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis.
    Ponce-Alonso M; García-Hoz C; Halperin A; Nuño J; Nicolás P; Martínez-Pérez A; Ocaña J; García-Pérez JC; Guerrero A; López-Sanromán A; Cantón R; Roy G; Del Campo R
    Front Immunol; 2021; 12():683387. PubMed ID: 34149723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea.
    Kang GU; Park S; Jung Y; Jee JJ; Kim MS; Lee S; Lee DW; Shin JH; Koh H
    Gut Liver; 2022 Sep; 16(5):775-785. PubMed ID: 35975640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
    Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
    J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis.
    Leonardi I; Paramsothy S; Doron I; Semon A; Kaakoush NO; Clemente JC; Faith JJ; Borody TJ; Mitchell HM; Colombel JF; Kamm MA; Iliev ID
    Cell Host Microbe; 2020 May; 27(5):823-829.e3. PubMed ID: 32298656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.
    Fuentes S; Rossen NG; van der Spek MJ; Hartman JH; Huuskonen L; Korpela K; Salojärvi J; Aalvink S; de Vos WM; D'Haens GR; Zoetendal EG; Ponsioen CY
    ISME J; 2017 Aug; 11(8):1877-1889. PubMed ID: 28398347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.